MedTrace Logo

Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

NCT02145013 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-02-12

No results posted yet for this study

Summary

According to the BCLC guidelines, surgical resection of hepatocellular carcinoma complicating cirrhosis is restricted to patients with preserved liver function, single nodule without vascular invasion and with hepatic venous gradient below 10 mmHg.

However, other guideline treatment, especially from eastern countries demonstrated that surgical resection is safe and feasible and provides better survival than the treatment recommended by the BCLC system for patients with similar stage.

The primary goal of this study is to assess the impact of HVPG on short and long-term outcomes in HCC patients who undergo liver resection.

Conditions

  • Primary Liver Cancers

Interventions

PROCEDURE

Liver resection

Hepatectomy by either open, laparoscopic or robotic procedures

Sponsors & Collaborators

  • Henri Mondor University Hospital

    lead OTHER

Principal Investigators

  • Daniel Azoulay, MD PhD · Henri Mondor

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-12-31
Completion
2018-05-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02145013 on ClinicalTrials.gov